New hope for tough brain tumors: drug trial targets recurrent meningioma
Disease control
Not yet recruiting
This study tests a drug called zanzalintinib in 100 people with meningioma (a type of brain tumor) that has returned or grown despite standard treatments like surgery or radiation. The goal is to see if the drug can shrink tumors or slow their growth. Participants take the drug b…
Phase: PHASE2 • Sponsor: Exelixis • Aim: Disease control
Last updated May 17, 2026 02:38 UTC